Schaber said Kanzer’s behavior “was not in the company’s control.” “On behalf of DOR, its employees, and our external advisors, we definitely apologize for that incident,” Schaber said to The Cancer Letter. “The company does not condone that, and we are not pleased with that. It had nothing to do with the company. It was an individual.”